In a burst of IPO activity, Ropes & Gray represented, among other clients in other offerings, clients in two life sciences IPOs with an aggregate value of $540 million:
- The underwriters in Bicara Therapeutics’ $315 million initial public offering, which priced on Sept. 12. The deal team included capital markets partner Tom Danielski and counsel Ray Grant. The transaction is the third-largest IPO of the year, according to BioPharma Dive data.
- Zenas BioPharma in its $225 million initial public offering, which priced on Sept. 12 and was announced in a press release. The deal team included capital markets partner Tom Danielski and counsel Nicholas Roper, executive compensation & employee benefits partner Ellen Sueda,health care partner Eve Brunts, and life sciences regulatory & compliance partner Kellie Combs.
LEGAL DESIRE NEWSLETTER
Where the legal industry reads first.
Enjoyed this article? Get the biggest legal industry updates, deals, appointments, insights and expert interviews in your inbox, free.
No spam. Unsubscribe anytime.From Legal Desire
Is your firm the one being cited, or the one being skipped?
We ran the test. On several everyday legal questions, software companies are answering and law firms are not. We help firms fix that, and we build the technology behind the practice.
See the full deal record on DealDatabase
The advising firms, the named deal team, the value and the parties, with every other announced deal by the same firms and lawyers. Open the deal record
The advising firms, the named deal team, the value and the parties, with every other announced deal by the same firms and lawyers. Open the deal record
